Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Miropasz is a Polish company specializing in the processing of Category 3 poultry by-products into proteins and fats for use in animal feed and petfood. The company operates three rendering plants in southeast Poland and processes approximately 250,000 metric tons of poultry by-products annually. It was acquired by Darling Ingredients in 2023 for €110 million and maintains high quality standards with certifications such as GMP+ and FSSC 22000.[1][2][3][4][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Miropasz.